HR Execs on the Move

Graymark Healthcare

www.graymarkhealthcare.com

 
Graymark Healthcare, Inc. (Graymark) is a diversified healthcare services company, which conducts business in two operating segments, Sleep Management Solutions and Apothecary. Sleep Management Solutions (SMS), is a provider of care management solutions
  • Number of Employees: 250-1000
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

MedicSight

MedicSight is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Korman Healthcare

Korman Healthcare is a Chandler, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Bioanalytical Instruments

Bioanalytical Instruments is a Carolina, PR-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Starion Instruments Corporation

Starion Instruments Corporation is a Sunnyvale, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Neurolens

Modern lifestyles and persistent near vision utilization cause a majority of patients to experience the reduced visual acuity and painful symptoms of eye misalignment – headaches, eye strain, neck and shoulder pain, motion sickness and dry eye sensation. Neurolens addresses common binocular vision issues using a three-step process. Step one is efficiently identifying patient symptomology using a basic online symptom screener that every patient can complete in minutes. This information goes directly to the Neurolens Measurement Device, Gen 2—or NMD2—ready for step two, which is accurately and objectively measuring the patient`s level of misalignment. The NMD2 is an objective, accurate and repeatable way to measure eye misalignment as small as 0.01 Prism Diopters. Most importantly, step three is correcting eye misalignment with a proven lens solution. Neurolenses address binocular vision issues by providing a contoured prism lens design that gradually delivers more prism in the lens corridor from distance to near. Neurolenses are proven to have a profound impact on a patient`s visual clarity and comfort. In fact, 93% of patients responded positively to wearing Neurolenses. Over 81% of patients suffering from chronic daily headaches reported their symptoms were substantially reduced or basically gone after wearing Neurolenses for 90 days. Neurolens—recognized in 2022 as one of the 30 fastest growing private companies in the healthcare industry by Inc. Magazine—is confident that appropriately addressing growing binocular vision issues will become a standard of care in this industry, unlocking dramatic patient outcomes and practice growth.